Qianliang Wang

616 citations
30 papers · 471 indexed · h-index 12

Qianliang Wang

26 papers receiving 468 citations

Peers

Qianliang Wang
Comparison fields: 5 of 89
  • Cancer Research 89
  • Molecular Biology 252
  • Pathology and Forensic Medicine 59
  • Immunology 69
  • Pharmacology 50
Replace Michal Entin‐Meer with:
Michal Entin‐Meer Israel
Sadatsugu Sakane Japan
Yingmin Zhang China
Meihui He China
Xiaoming Zhong China
Zhengdong Liang United States
Zhongyi Tong China
Jian Pang China
Minghua Li China
Joseph R. Inigo United States
Qianliang Wang relative to Michal Entin‐Meer Israel Michal Entin‐Meer's profile →
Citations per field
00.5×1.5×2.5×
Michal Entin‐Meer · 1×
Citations per year

Countries citing papers authored by Qianliang Wang

Since Specialization
Citations

This map shows the geographic impact of Qianliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianliang Wang more than expected).

Fields of papers citing papers by Qianliang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qianliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianliang Wang. The network helps show where Qianliang Wang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Qianliang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Qianliang Wang Line = papers co-authored together Qianliang Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20250
3 20251
4 20253
5 20240
6 20240
7 20243
8 20245
9 20238
10 20221
11 20225
12 202162
13 202116
14 201922
15 201731
16 201614
17 201520
18 20156
19 20155
20 201421

About Qianliang Wang

Qianliang Wang is a scholar working on Pathology and Forensic Medicine, Pharmacology, Biochemistry, Cancer Research and Surgery, having authored 30 papers that have together received 471 indexed citations. Recurring topics across this work include Spine and Intervertebral Disc Pathology (7 papers), Pain Mechanisms and Treatments (5 papers), Anesthesia and Pain Management (3 papers), Spinal Hematomas and Complications (3 papers), RNA Research and Splicing (3 papers), interferon and immune responses (2 papers), Blood transfusion and management (2 papers) and Musculoskeletal pain and rehabilitation (2 papers). The work is most often cited by research in Cancer Research (89 citations), Molecular Biology (252 citations), Pathology and Forensic Medicine (59 citations), Immunology (69 citations) and Pharmacology (50 citations). Qianliang Wang has collaborated with scholars based in China and United States. Frequent co-authors include Tianshou Zhou, Jun Yan, Xiaoqiang Sun, Jiajun Zhang, Ji Zhang, Kang Zou, Rongfu Wang, Chunmei Cai, Tingzhe Sun and Weihong Xie. Their work appears in journals such as BMC Musculoskeletal Disorders, Molecular Pain, The Journal of Cell Biology, Scientific Reports and Cellular and Molecular Neurobiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026